These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Serum concentration and kinetics after i.v.-infusion of 3 g lincomycin (author's transl)]. Adam D, Pätzold J. Arzneimittelforschung; 1979; 29(1):130-4. PubMed ID: 582106 [Abstract] [Full Text] [Related]
9. [The toxicity of lincomycin. Two i.v. applications of 6 g. each to a 10 year old girl without toxic symptoms]. Widhalm K, Salzman G. Arzneimittelforschung; 1978; 28(8):1428-30. PubMed ID: 582412 [Abstract] [Full Text] [Related]
10. [Excretion of erythromycin, clindamycin and lincomycin into the saliva]. Kelentey BA, Kelentey BJ. Fogorv Sz; 1995 Jul; 88(7):219-24. PubMed ID: 8522016 [Abstract] [Full Text] [Related]
12. [Lincomycin concentration in human serum and pulmonary tissue]. Faragó E, Kiss J, Kollár S, Nabrady Z. Antibiotiki; 1977 Jan; 22(1):54-6. PubMed ID: 843073 [Abstract] [Full Text] [Related]
13. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, Cunningham G, Smith HA, Campbell A, Canter JA, Christian KG, Drinkwater DC, Scholl F, Kavanaugh-McHugh A, Summar ML. J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768 [Abstract] [Full Text] [Related]